Suppr超能文献

唾液链球菌 NU10 产生的林可霉素 9 类抗生素的增强生产、纯化、特性和作用机制。

Enhanced production, purification, characterization and mechanism of action of salivaricin 9 lantibiotic produced by Streptococcus salivarius NU10.

机构信息

Institute of Biological Sciences, Microbiology Division, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

PLoS One. 2013 Oct 16;8(10):e77751. doi: 10.1371/journal.pone.0077751. eCollection 2013.

Abstract

BACKGROUND

Lantibiotics are small lanthionine-containing bacteriocins produced by lactic acid bacteria. Salivaricin 9 is a newly discovered lantibiotic produced by Streptococcus salivarius. In this study we present the mechanism of action of salivaricin 9 and some of its properties. Also we developed new methods to produce and purify the lantibiotic from strain NU10.

METHODOLOGY/PRINCIPAL FINDINGS: Salivaricin 9 was found to be auto-regulated when an induction assay was applied and this finding was used to develop a successful salivaricin 9 production system in liquid medium. A combination of XAD-16 and cation exchange chromatography was used to purify the secondary metabolite which was shown to have a molecular weight of approximately 3000 Da by SDS-PAGE. MALDI-TOF MS analysis indicated the presence of salivaricin 9, a 2560 Da lantibiotic. Salivaricin 9 is a bactericidal molecule targeting the cytoplasmic membrane of sensitive cells. The membrane permeabilization assay showed that salivaricin 9 penetrated the cytoplasmic membrane and induced pore formation which resulted in cell death. The morphological changes of test bacterial strains incubated with salivaricin 9 were visualized using Scanning Electron Microscopy which confirmed a pore forming mechanism of inhibition. Salivaricin 9 retained biological stability when exposed to high temperature (90-100°C) and stayed bioactive at pH ranging 2 to 10. When treated with proteinase K or peptidase, salivaricin 9 lost all antimicrobial activity, while it remained active when treated with lyticase, catalase and certain detergents.

CONCLUSION

The mechanism of antimicrobial action of a newly discovered lantibiotic salivaricin 9 was elucidated in this study. Salivaricin 9 penetrated the cytoplasmic membrane of its targeted cells and induced pore formation. This project has given new insights on lantibiotic peptides produced by S. salivarius isolated from the oral cavities of Malaysian subjects.

摘要

背景

类细菌素是由乳酸菌产生的含有小硫醚键的小肽。唾液菌素 9 是一种新发现的由唾液链球菌产生的类细菌素。在本研究中,我们介绍了唾液菌素 9 的作用机制及其一些特性。此外,我们还开发了从 NU10 菌株生产和纯化类细菌素的新方法。

方法/主要发现:当应用诱导试验时,发现唾液菌素 9 是自我调节的,这一发现被用于开发一种在液体培养基中成功生产唾液菌素 9 的系统。XAD-16 和阳离子交换层析的组合用于纯化次级代谢产物,SDS-PAGE 显示其分子量约为 3000 Da。MALDI-TOF MS 分析表明存在唾液菌素 9,一种 2560 Da 的类细菌素。唾液菌素 9 是一种针对敏感细胞细胞质膜的杀菌分子。膜通透性试验表明,唾液菌素 9 穿透细胞质膜并诱导孔形成,导致细胞死亡。用扫描电子显微镜观察与唾液菌素 9 孵育的试验菌株的形态变化,证实了一种抑制的孔形成机制。唾液菌素 9 在暴露于高温(90-100°C)时保持生物稳定性,并在 pH 值为 2 至 10 范围内保持生物活性。当用蛋白酶 K 或肽酶处理时,唾液菌素 9 失去所有抗菌活性,而用溶菌酶、过氧化氢酶和某些清洁剂处理时,它仍保持活性。

结论

本研究阐明了新发现的唾液菌素 9 的抗菌作用机制。唾液菌素 9 穿透其靶细胞的细胞质膜并诱导孔形成。该项目为从马来西亚受试者口腔中分离出的唾液链球菌产生的类细菌素肽提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f03c/3797685/45bd49e29bc1/pone.0077751.g008.jpg

相似文献

2
Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjects.
PLoS One. 2014 Jun 18;9(6):e100541. doi: 10.1371/journal.pone.0100541. eCollection 2014.
3
Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius.
Microbiology (Reading). 2011 May;157(Pt 5):1290-1299. doi: 10.1099/mic.0.044719-0. Epub 2011 Feb 10.
4
Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2.
Appl Environ Microbiol. 2018 Feb 14;84(5). doi: 10.1128/AEM.02528-17. Print 2018 Mar 1.
5
New insights into the mode of action of the lantibiotic salivaricin B.
Sci Rep. 2016 Aug 16;6:31749. doi: 10.1038/srep31749.
6
Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant.
Appl Environ Microbiol. 2012 Jan;78(2):402-10. doi: 10.1128/AEM.06588-11. Epub 2011 Nov 18.
8
Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.
Antonie Van Leeuwenhoek. 2006 Oct;90(3):269-80. doi: 10.1007/s10482-006-9081-y. Epub 2006 Jul 27.
10
Evolution of Lantibiotic Salivaricins: New Weapons to Fight Infectious Diseases.
Trends Microbiol. 2020 Jul;28(7):578-593. doi: 10.1016/j.tim.2020.03.001. Epub 2020 Apr 6.

引用本文的文献

3
Exploring the bioactive landscape: peptides and non-peptides from the human microbiota.
NPJ Biofilms Microbiomes. 2025 May 8;11(1):76. doi: 10.1038/s41522-025-00713-x.
4
The Genomic Characteristics of Potential Probiotics: Two Isolates from a Healthy Individual in China.
Microorganisms. 2025 Mar 20;13(3):694. doi: 10.3390/microorganisms13030694.
5
and : Paragons of Probiotic Potential and Reservoirs of Novel Antimicrobials.
Microorganisms. 2025 Feb 28;13(3):555. doi: 10.3390/microorganisms13030555.
6
Effects of Preservation and Propagation Methodology on Microcosms Derived from the Oral Microbiome.
Microorganisms. 2022 Oct 29;10(11):2146. doi: 10.3390/microorganisms10112146.
7
Oral Commensal Streptococci: Gatekeepers of the Oral Cavity.
J Bacteriol. 2022 Nov 15;204(11):e0025722. doi: 10.1128/jb.00257-22. Epub 2022 Oct 26.
8
The bacteriocin Angicin interferes with bacterial membrane integrity through interaction with the mannose phosphotransferase system.
Front Microbiol. 2022 Sep 6;13:991145. doi: 10.3389/fmicb.2022.991145. eCollection 2022.
9
Mechanism of Action of Ribosomally Synthesized and Post-Translationally Modified Peptides.
Chem Rev. 2022 Sep 28;122(18):14722-14814. doi: 10.1021/acs.chemrev.2c00210. Epub 2022 Sep 1.
10
Angicin, a novel bacteriocin of Streptococcus anginosus.
Sci Rep. 2021 Dec 21;11(1):24377. doi: 10.1038/s41598-021-03797-5.

本文引用的文献

1
Genetic characterisation and heterologous expression of leucocin C, a class IIa bacteriocin from Leuconostoc carnosum 4010.
Appl Microbiol Biotechnol. 2013 Apr;97(8):3509-18. doi: 10.1007/s00253-012-4406-4. Epub 2012 Oct 9.
3
Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application.
Expert Opin Drug Discov. 2011 Feb;6(2):155-70. doi: 10.1517/17460441.2011.545387. Epub 2011 Jan 18.
5
Lantibiotics biosynthesis genes and bacteriocinogenic activity of Lactobacillus spp. isolated from raw milk and cheese.
Folia Microbiol (Praha). 2012 May;57(3):183-90. doi: 10.1007/s12223-012-0113-x. Epub 2012 Mar 24.
6
Transcription analysis of a lantibiotic gene cluster from Bifidobacterium longum DJO10A.
Appl Environ Microbiol. 2011 Sep;77(17):5879-87. doi: 10.1128/AEM.00571-11. Epub 2011 Jul 8.
7
Lantibiotics as probes for phosphatidylethanolamine.
Amino Acids. 2011 Nov;41(5):1071-9. doi: 10.1007/s00726-009-0386-9. Epub 2009 Nov 22.
8
Commercial development and application of type A lantibiotics.
Recent Pat Antiinfect Drug Discov. 2011 May;6(2):175-85. doi: 10.2174/157489111796064632.
9
Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin.
ACS Chem Biol. 2011 Jul 15;6(7):744-52. doi: 10.1021/cb1004178. Epub 2011 May 5.
10
Production, purification, sequencing and activity spectra of mutacins D-123.1 and F-59.1.
BMC Microbiol. 2011 Apr 10;11:69. doi: 10.1186/1471-2180-11-69.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验